These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8235570)

  • 1. Drug therapy for hyperlipidemia.
    Hedge D
    S D J Med; 1993 Jul; 46(7):234-5. PubMed ID: 8235570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of hyperlipemias].
    Wollenweber J
    ZFA (Stuttgart); 1976 Nov; 52(32):1674-7. PubMed ID: 1020431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-hyperlipidemic drug].
    Nakaya N
    Nihon Rinsho; 1999 Jul; 57(7):1570-6. PubMed ID: 10429459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The mechanisms of action of etophylline-clofibrate in hyperlipidemia].
    Păduraru I; Nechifor M; Dănilă G; Jercă L; Filip M; Iacobovici A; Teslaru E; Filip C; Saramet A
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):445-9. PubMed ID: 8153471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypolipidemic agents and their indication].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():559-65. PubMed ID: 11347132
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of essential hyperlipidemia with procetofene. Apropos of 100 cases].
    Fromantin M; Gautier D; Bon R
    Sem Hop Ther; 1977; 53(5-6):311-6. PubMed ID: 897691
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical management of hyperlipidemia/dyslipidemia.
    Kreisberg RA; Oberman A
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2445-61. PubMed ID: 12788840
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and future therapeutic approaches to hyperlipidemia.
    Farmer JA; Gotto AM
    Adv Pharmacol; 1996; 35():79-114. PubMed ID: 8920205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic of acetiromate on hyperlipidemia--comparison with clofibrate using a double-blind method].
    Nakano Y; Fukui I; Niiho S; Kuki H; Takahata J
    Nihon Rinsho; 1974 Jul; 32(7):2526-51. PubMed ID: 4612204
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of CH 13.437 in different types of hyperlipidemia.
    Harvengt C
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547
    [No Abstract]   [Full Text] [Related]  

  • 13. Around PediHeart: hyperlipidemia.
    McCaffrey F
    Pediatr Cardiol; 2001; 22(1):52. PubMed ID: 11123128
    [No Abstract]   [Full Text] [Related]  

  • 14. Getting the skinny on lipid-lowering drugs.
    Kuncl N; Nelson KM
    Nursing; 2000 Jul; 30(7):52-3. PubMed ID: 10983101
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid disorders. Summary and table.
    Coleman SG; Brooke G
    Drugs R D; 1999 Jun; 1(6):471-5. PubMed ID: 10566086
    [No Abstract]   [Full Text] [Related]  

  • 16. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetically defined hyperlipidemia.
    Smit JW; Diamant M
    Pharmacogenomics; 2004 Apr; 5(3):295-304. PubMed ID: 15102544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-hyperlipidemic agents].
    Kinoshita M
    Nihon Rinsho; 2002 May; 60(5):968-74. PubMed ID: 12030001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperlipidemia].
    Wakatsuki A
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():375-80. PubMed ID: 16689337
    [No Abstract]   [Full Text] [Related]  

  • 20. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.